Clensta Shark Tank India Pitch Introduction
Clensta Shark Tank India appearance marked a significant moment for sustainable hygiene solutions in the Indian startup ecosystem. Founder Puneet Gupta entered the tank with a bold vision to solve India’s looming water crisis through innovative personal care products. His opening statement highlighted a stark reality: by 2030, nearly 40% of Indians may lack access to drinking water according to NITI Aayog projections. Clensta positions itself as a biotechnology-driven brand offering waterless body bath and shampoo solutions that require no water rinse, making it ideal for hospitals, defense forces, travelers, and water-scarce regions.
The entrepreneur sought an investment of ₹1 Crore in exchange for just 1% equity, valuing the company at ₹100 Crores. With operations already spanning 25,000 outlets globally and strong research backing from IIT Delhi, the pitch promised a blend of social impact and commercial scalability. However, the Sharks soon uncovered challenges regarding business focus, profitability, and brand positioning that ultimately led to all five declining the opportunity.
Business Overview and Product Innovation
Clensta operates at the intersection of biotechnology and personal hygiene, creating waterless alternatives to traditional bathing and hair care. The flagship product is a waterless body bath formulated as a spray-based solution containing no alcohol, designed to be applied directly to the skin, lightly rubbed, and towel-dried without requiring water rinse. This addresses critical pain points for bedridden patients, trekkers, military personnel in field operations, and regions facing acute water shortages.
Beyond personal care, Clensta has expanded into home care solutions including surface cleaners and unique innovations like pigeon repellent technology. The business model initially focused on B2B channels, securing adoption from prestigious medical institutions including AIIMS, Medanta, and Apollo Hospitals, where infection control and patient hygiene are paramount. The company emphasizes eco-friendly formulations that conserve approximately 350 liters of water per bottle compared to traditional bathing methods.
| Company Attribute | Details |
|---|---|
| Founder | Puneet Gupta |
| Founded Year | 2016 |
| Headquarters | Delhi, India |
| Primary Category | Waterless Personal Hygiene |
| Technology Partner | IIT Delhi Incubation |
| Key Products | Waterless Body Bath, Shampoo, Home Care |
Founder Journey and Background
Puneet Gupta brings a biotechnology engineering background to the consumer goods sector, distinguishing Clensta as a science-first brand rather than a typical FMCG marketing play. Although not an IIT Delhi graduate himself, Gupta strategically leveraged the institution’s incubation program and Biotechnology Center to access critical research infrastructure and instrumentation necessary for product development. This partnership proved instrumental in creating clinically validated formulations that could meet hospital-grade standards.
Before committing full-time to Clensta, Gupta worked in corporate roles for six to seven years, saving approximately half a million dollars which he invested as seed capital into the business. The company operated as a bootstrapped entity for the first two years before raising external funding. Gupta emphasized his hands-on approach, personally driving sales and managing operations during the initial phase, which helped the company achieve significant B2B traction before expanding into consumer markets.
- Biotechnology engineer with research-focused approach
- Bootstrapped for initial two years with personal savings
- Leveraged IIT Delhi incubation for R&D infrastructure
- Personally handled initial sales and hospital network building
- Expanded from single product to 360-degree home care portfolio
Sharks and Founders QnA Session
Ashneer Grover: Are you yourself from IIT Delhi?
No, I am not from IIT Delhi. I am a biotechnology engineering graduate. I needed instruments and infrastructure for research, so I approached IIT Delhi, applied for their incubation program, and they supported us at the Biotechnology Center where we developed all our products.
Namita Thapar: What did you do before starting this business? Did you do any other business or job?
I worked for six to seven years in a job. I invested about half a million dollars from my savings into this business. The first two years were completely bootstrapped.
Ashneer Grover: Tell me about your funding rounds one by one. How much did you raise, at what valuation, and from whom?
I raised the first round in September 2018 for ₹80 Lakhs from Sanjeev Jain at a ₹20 Crore valuation. Then I did a convertible note round of half a million dollars at a ₹32 Crore valuation. After that, I raised ₹1.25 Crore as a bridge round which converted at a ₹40 Crore valuation. Recently in April, we closed a round at a ₹90 Crore valuation where I raised ₹20 Crore total—₹15 Crore equity and ₹5 Crore debt.
Anupam Mittal: Who participated in this recent round? Did IPV invest?
Yes, IPV and others invested in this round.
Peyush Bansal: Which Shark here would want to bathe without water?
Actually, we can see the demonstration. This is our wireless body bath. I have already taken a bath today, but I will show you. You just have to spray it like this, rub it a little bit, and towel dry. You have to do this on the whole body.
Vineeta Singh: Is there alcohol in this product?
No, this product is completely alcohol-free.
Peyush Bansal: If this is your product, then why do you have so many products? You have surface cleaners and pigeon repellents?
Clensta is a hygiene brand. We first launched waterless products. Recently, we launched 360-degree home care solutions including smart concentrates. For example, this pigeon repellent keeps birds away.
Aman Gupta: How much of your current sales come from old products versus new products?
Last year we did about ₹13.5 Crores in sales, all from the waterless body bath category. Currently, in the last three months, we are getting about ₹50 Lakhs monthly contribution from home care and about ₹1 Crore from the waterless category.
Namita Thapar: Compared to wet wipes which cost ₹1, this is very expensive at ₹500. Who buys this?
Hospitals buy this. AIIMS, Medanta, Apollo conducted trials against sponge baths and wet wipes, and they had to implement it because it really helps in infection control for patients.
Ashneer Grover: If your waterless sales were ₹12 Crores last year and this year they are ₹12 Crores, that means sales have decreased, not increased. So why has your valuation gone up?
This is not correct. These products are very time-consuming to develop. Research takes six months, patents take time, stability testing takes time—so 18 months go into developing one clinically validated product. I have just raised investment, so going forward, if I do not do horizontal scaling, the burn will never reduce.
Aman Gupta: I have a fundamental question about branding. You are saying you are a personal care brand, but you also have surface cleaners and toilet cleaners under the same brand. I would never use a toilet cleaner brand on my body.
That is true. As a founder, I am learning. I have to figure out many things myself. I call founder friends and ask what they did. The purpose of coming to Shark Tank was that you Sharks can help us.
Anupam Mittal: You are very honest, but do you take too long to learn? You started in 2016, today it has been 5 years. These fundamental branding issues should have been figured out in the first 2 years.
Learning never ends. But I have made my decision, and I am out. The reason is simple—I feel you are very distracted. You want to become a celebrated founder, not build a business. Your business was B2B, you took the valuation, and now you are building this consumer business to justify that valuation. There is no inner voice saying I want to make toilet cleaner or body wash. This is compulsion, not attraction.
Namita Thapar: My decision is also out. One, I feel your strength is this discovery you have made, but everything after that—branding, packaging—is quite average. There are lakhs of Harpic-looking products in the market. A brand is not built that way.
I am out for this reason.
Vineeta Singh: I think you tried to create a new category, but there was not enough scope in that category, so you expanded horizontally into new categories. There is no harm in that. You will fall, get up, and learn. I want to know the potential. If I talk about the next 5 years, we are targeting about ₹1000 Crores.
Next year our target is about ₹60 Crores. Will you be profitable? No, we will not be profitable next year. We will be profitable the year after because the objective of raising this round was that we have not spent on branding or marketing yet, as that money does not return immediately.
Aman Gupta: I have made my decision. One, this brand you have made for personal care and cleaning makes no sense to me. Second, you are quite distracted and confused. When we ask you questions, you do not answer precisely and go everywhere. I think you need a co-founder who can help you with branding, positioning, and strategy. I cannot be that person, so I am out.
It was quite interesting when you came, but now you have become distracted. You are leaving your USP—technology—and now you want to learn branding and marketing. You feel the company will grow through marketing, not biotech. For this reason, I am out.
Peyush Bansal: Everyone in the world gives gyaan. Everyone feels they know everything. But a founder knows what is right and wrong. If you feel there is potential in this market and you can do it, then do it. I am out because it will take time to prove this new category, and as an entrepreneur, you have started looking inward.
Keep doing it for 6 months, 1 year, 2 years, but do not get confused and focus on one thing.
Key Stats and Financial Performance
Clensta’s financial trajectory reveals a company in transition from a focused B2B player to a diversified consumer brand. While the top-line showed promise with established hospital networks, the founder’s admission of non-profitability and decreasing core category sales raised red flags during the pitch. The company had already raised significant capital at escalating valuations before appearing on the show.
- Last FY Sales: ₹13.5 Crore (Waterless category only)
- Current Monthly Sales: ₹1.5 Crore combined (₹1 Cr Waterless + ₹50L Home Care)
- Original Ask: ₹1 Crore for 1% Equity
- Valuation Requested: ₹100 Crore
- Recent Pre-Shark Tank Valuation: ₹90 Crore (April 2021)
- Profitability Status: Negative cash flow, targeting profitability in 2 years
| Financial Metric | Amount/Status |
|---|---|
| Initial Ask | ₹1 Crore for 1% |
| Previous Valuation | ₹90 Crore (Recent) |
| Total Funding Raised | ₹20 Crore + Earlier Rounds |
| Last Year Revenue | ₹13.5 Crore |
| Monthly Burn Rate | High (Expansion Phase) |
| Deal Outcome | No Deal |
Business Potential and Total Addressable Market
The waterless hygiene market addresses a genuine and growing need in water-scarce economies like India. With NITI Aayog projecting that 40% of Indians will lack access to drinking water by 2030, Clensta’s value proposition extends beyond convenience to necessity. The B2B healthcare segment alone presents a substantial opportunity, as infection control and patient hygiene become priorities for hospitals seeking alternatives to sponge baths that can spread bacteria.
However, the Sharks questioned whether Clensta could capture this TAM effectively given their branding confusion and founder distraction. The expansion into home care products like surface cleaners and pigeon repellents, while potentially lucrative, diluted the brand’s core identity according to the investors. The company projected reaching ₹1000 Crore in revenue within 5 years and ₹60 Crore in the immediate next year, but without a clear path to profitability or focused brand positioning, these projections appeared optimistic to the panel.
- Target Waterless Hygiene Market: ₹5000+ Crore by 2030
- Primary B2B Segment: 50,000+ Hospitals in India
- Defense and Military Applications: Significant untapped potential
- Elderly Care Market: Rapidly growing demographic need
- Adventure Tourism: Trekking and camping segments
| Target Segment | Use Case |
|---|---|
| Hospitals/Medical | Patient hygiene, infection control |
| Defense Forces | Field operations, water-scarce zones |
| Elderly Care | Bedridden patient bathing |
| Adventure Travel | Camping, trekking, mountaineering |
| Urban Consumers | Water conservation, quick refresh |
| Home Care | Surface cleaning, pest control |
Marketing and Distribution Strategy
Clensta’s distribution strategy has historically relied on institutional B2B sales through direct relationships with hospital chains and medical facilities. The founder emphasized that products like the waterless body bath were adopted by AIIMS, Medanta, and Apollo only after extensive clinical trials proving superiority over traditional sponge baths and wet wipes for infection control. This medical validation served as the primary marketing credential for the brand.
Post-funding, the company planned to pivot toward consumer branding and marketing—a shift that concerned the Sharks given the founder’s admission of lacking expertise in this area. The strategy involved expanding the product portfolio horizontally into home care categories including surface cleaners and pigeon repellents, available through 25,000 retail outlets. However, this broad approach contradicted the focused branding required to build consumer trust in a novel category like waterless bathing.
- B2B First Approach: Hospital and institutional sales
- Clinical Validation: Trials at premier medical institutions
- Retail Expansion: 25,000+ outlets including Health and Glow
- E-commerce Presence: Available on Amazon, Tata 1MG
- Portfolio Expansion: Moving into home care and cleaning
Clensta Deal Outcome on Shark Tank India
Despite an innovative product with genuine social impact potential, Clensta failed to secure investment from any of the five Sharks. The unanimous decision stemmed from concerns about founder focus, brand identity confusion, and valuation disconnect rather than the product quality itself. Each Shark provided specific feedback regarding the business’s strategic direction before declaring themselves out.
| Shark | Decision |
|---|---|
| Ashneer Grover | Out – Founder distracted, building for valuation not business |
| Namita Thapar | Out – Branding and packaging too average for category creation |
| Anupam Mittal | Out – Fundamental issues should have been solved by year 2 |
| Vineeta Singh | Out – Time to prove category too long, founder turned inward |
| Aman Gupta | Out – Needs co-founder for branding, confused positioning |
Clensta Post-Show Update
Following the Shark Tank India appearance, Clensta continued its growth trajectory despite not securing a deal. According to reports from March 2024, the company achieved significant milestones including 300% growth in FY24 and crossing the ₹100 Crore revenue mark. High-profile celebrity backing came through actress Parineeti Chopra, who invested in the company and became a brand ambassador, providing the marketing credibility the Sharks felt was missing during the pitch.
The company expanded its retail presence through partnerships with Health and Glow, Tata 1MG, and other major chains while continuing to serve the B2B hospital segment. The waterless hygiene category, which Clensta pioneered in India, gained increased attention as water conservation became a more prominent consumer concern. The founder appears to have taken the Sharks’ advice to heart regarding the need for focused brand building, though the company continues to operate across both personal care and home care categories.
Business Analysis and Key Lessons
The Clensta pitch offers several critical lessons for D2C entrepreneurs, particularly those operating in category creation spaces. First, technology and product innovation alone do not guarantee success; brand positioning and consumer psychology play equally important roles. The Sharks consistently emphasized that mixing toilet cleaners and personal hygiene products under one brand creates irreconcilable cognitive dissonance for consumers, destroying brand equity regardless of product efficacy.
Second, founder focus and self-awareness matter more than valuation metrics. Puneet Gupta’s admission that he was still learning fundamental branding concepts after five years in business signaled to investors that the company lacked strategic direction. The pivot from B2B medical sales to mass-market consumer goods requires fundamentally different skill sets—marketing versus sales, brand building versus clinical validation—that cannot be learned simultaneously while managing cash burn.
- Category creation requires patient capital and focused branding
- B2B and B2C require fundamentally different go-to-market strategies
- Horizontal expansion can dilute core brand value
- Founders must acknowledge skill gaps and recruit complementary talent
- Valuation must align with revenue traction and profitability timeline
Clensta Shark Tank India Pitch Conclusion
Clensta represents the classic innovator’s dilemma: possessing breakthrough technology but struggling with commercial execution and brand architecture. While the waterless hygiene solution addresses a critical environmental and healthcare need, the company’s diffuse focus across multiple product categories and lack of branding clarity prevented the Sharks from investing despite the impressive ₹100 Crore valuation ask.
For entrepreneurs watching this pitch, the key takeaway is that investors invest in focused execution as much as innovative ideas. Clensta’s post-show growth suggests the market opportunity remains valid, but the Shark Tank critique regarding the need for concentrated brand positioning and potentially a co-founder with consumer marketing expertise appears prescient. What are your thoughts on Clensta’s portfolio approach? Share your views in the comments below.